# Parke Bancorp, Inc.: financial statements, quarterly

PKBK · Nasdaq · CIK 1315399 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pkbk.md) · [Financials](/companies/pkbk/financials.md) · [Filings](/companies/pkbk/filings.md) · [Insiders](/companies/pkbk/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pkbk/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [13.4](/filings/0001315399-23-000075.md) | [14.8 d](/filings/0001315399-24-000024.md) | [15.4](/filings/0001315399-24-000038.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.3](/filings/0001315399-24-000082.md) | [3.0 d](/filings/0001315399-25-000025.md) | [2.2](/filings/0001315399-25-000046.md) | [2.3](/filings/0001437749-25-025079.md) | [1.9](/filings/0001437749-25-033355.md) | [2.3 d](/filings/0001437749-26-007748.md) | [2.5](/filings/0001437749-26-015152.md) | [2.7](/filings/0001437749-26-025857.md) | [2.9](/filings/0001437749-25-033355.md) | [3.5 d](/filings/0001437749-26-007748.md) | [3.7](/filings/0001437749-26-015152.md) | [4.0](/filings/0001437749-26-025857.md) |
| Net income | $m | [1.0](/filings/0001315399-24-000082.md) | [8.2 d](/filings/0001315399-25-000025.md) | [6.2](/filings/0001315399-25-000046.md) | [6.5](/filings/0001437749-25-025079.md) | [7.5](/filings/0001437749-25-033355.md) | [7.4 d](/filings/0001437749-26-007748.md) | [7.8](/filings/0001437749-26-015152.md) | [8.3](/filings/0001437749-26-025857.md) | [10.6](/filings/0001437749-25-033355.md) | [11.1 d](/filings/0001437749-26-007748.md) | [11.8](/filings/0001437749-26-015152.md) | [12.2](/filings/0001437749-26-025857.md) |
| Diluted EPS | $ per share | [0.08](/filings/0001315399-24-000082.md) | not reported | [0.51](/filings/0001315399-25-000046.md) | [0.53](/filings/0001437749-25-025079.md) | [0.62](/filings/0001437749-25-033355.md) | not reported | [0.65](/filings/0001437749-26-015152.md) | [0.69](/filings/0001437749-26-025857.md) | [0.89](/filings/0001437749-25-033355.md) | not reported | [0.99](/filings/0001437749-26-015152.md) | [1.03](/filings/0001437749-26-025857.md) |
| Basic EPS | $ per share | [0.09](/filings/0001315399-24-000082.md) | not reported | [0.51](/filings/0001315399-25-000046.md) | [0.54](/filings/0001437749-25-025079.md) | [0.63](/filings/0001437749-25-033355.md) | not reported | [0.66](/filings/0001437749-26-015152.md) | [0.70](/filings/0001437749-26-025857.md) | [0.90](/filings/0001437749-25-033355.md) | not reported | [1.01](/filings/0001437749-26-015152.md) | [1.04](/filings/0001437749-26-025857.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [1,984](/filings/0001315399-23-000075.md) | [2,024](/filings/0001315399-25-000025.md) | [2,009](/filings/0001315399-24-000038.md) | [2,027](/filings/0001315399-24-000063.md) | [2,065](/filings/0001315399-24-000082.md) | [2,142](/filings/0001437749-26-007748.md) | [2,142](/filings/0001315399-25-000046.md) | [2,170](/filings/0001437749-25-025079.md) | [2,172](/filings/0001437749-25-033355.md) | [2,249](/filings/0001437749-26-025857.md) | [2,213](/filings/0001437749-26-015152.md) | [2,303](/filings/0001437749-26-025857.md) |
| Total liabilities | $m | [1,706](/filings/0001315399-23-000075.md) | [1,739](/filings/0001315399-25-000025.md) | [1,721](/filings/0001315399-24-000038.md) | [1,734](/filings/0001315399-24-000063.md) | [1,769](/filings/0001315399-24-000082.md) | [1,842](/filings/0001437749-26-007748.md) | [1,836](/filings/0001315399-25-000046.md) | [1,858](/filings/0001437749-25-025079.md) | [1,857](/filings/0001437749-25-033355.md) | [1,925](/filings/0001437749-26-025857.md) | [1,877](/filings/0001437749-26-015152.md) | [1,957](/filings/0001437749-26-025857.md) |
| Shareholders' equity | $m | [278](/filings/0001315399-24-000082.md) | [284](/filings/0001437749-26-007748.md) | [288](/filings/0001437749-25-025079.md) | [293](/filings/0001437749-25-033355.md) | [296](/filings/0001437749-25-033355.md) | [300](/filings/0001437749-26-025857.md) | [306](/filings/0001437749-26-025857.md) | [312](/filings/0001437749-26-025857.md) | [315](/filings/0001437749-25-033355.md) | [325](/filings/0001437749-26-025857.md) | [336](/filings/0001437749-26-025857.md) | [346](/filings/0001437749-26-025857.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(0.7) d](/filings/0001315399-24-000082.md) | [9.0 d](/filings/0001315399-25-000025.md) | [8.4](/filings/0001315399-25-000046.md) | [8.9 d](/filings/0001437749-25-025079.md) | [9.4 d](/filings/0001437749-25-033355.md) | [8.5 d](/filings/0001437749-26-007748.md) | [7.0](/filings/0001437749-26-015152.md) | [6.8 d](/filings/0001437749-26-025857.md) | [11.4 d](/filings/0001437749-25-033355.md) | [14.4 d](/filings/0001437749-26-007748.md) | [13.0](/filings/0001437749-26-015152.md) | [6.1 d](/filings/0001437749-26-025857.md) |
| Capital expenditure | $m | not reported | not reported | [0.0](/filings/0001315399-25-000046.md) | [0.0 d](/filings/0001437749-25-025079.md) | [0.0 d](/filings/0001437749-25-033355.md) | [0.0 d](/filings/0001437749-26-007748.md) | [0.4](/filings/0001437749-26-015152.md) | [0.1 d](/filings/0001437749-26-025857.md) | [0.1 d](/filings/0001437749-25-033355.md) | [0.0 d](/filings/0001437749-26-007748.md) | [0.1](/filings/0001437749-26-015152.md) | [0.2 d](/filings/0001437749-26-025857.md) |
| Dividends paid | $m | [2.2 d](/filings/0001315399-24-000082.md) | [2.2 d](/filings/0001315399-25-000025.md) | [2.2](/filings/0001315399-25-000046.md) | [2.2 d](/filings/0001437749-25-025079.md) | [2.1 d](/filings/0001437749-25-033355.md) | [2.1 d](/filings/0001437749-26-007748.md) | [2.1](/filings/0001437749-26-015152.md) | [2.1 d](/filings/0001437749-26-025857.md) | [2.1 d](/filings/0001437749-25-033355.md) | [2.0 d](/filings/0001437749-26-007748.md) | [2.1](/filings/0001437749-26-015152.md) | [2.1 d](/filings/0001437749-26-025857.md) |
| Share repurchases | $m | not reported | [0.0 d](/filings/0001315399-25-000025.md) | not reported | not reported | [2.0 d](/filings/0001437749-25-033355.md) | [2.2 d](/filings/0001437749-26-007748.md) | not reported | not reported | [6.5 d](/filings/0001437749-25-033355.md) | [0.0 d](/filings/0001437749-26-007748.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [12.2](/filings/0001315399-23-000075.md) | [12.2](/filings/0001315399-24-000038.md) | [12.1](/filings/0001315399-24-000063.md) | [12.1](/filings/0001315399-24-000082.md) | [12.1](/filings/0001315399-25-000046.md) | [12.1](/filings/0001437749-25-025079.md) | [12.2](/filings/0001437749-25-033355.md) | [12.0](/filings/0001437749-26-015152.md) | [12.0](/filings/0001437749-26-025857.md) | [12.0](/filings/0001437749-25-033355.md) | [11.9](/filings/0001437749-26-015152.md) | [11.9](/filings/0001437749-26-025857.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 11,761,470 at 2026-08-03, from the cover of the [10-Q filed 2026-08-05](/filings/0001437749-26-025857.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.